{"id":"org-50081","safety":{"commonSideEffects":[{"rate":null,"effect":"Testosterone suppression"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a SARM, Org 50081 selectively activates androgen receptors in muscle and bone tissue, promoting anabolism and potentially improving physical function and muscle mass. Unlike traditional androgens, SARMs are designed to have tissue-selective activity, reducing unwanted androgenic effects in prostate and other tissues. This selectivity profile makes it potentially suitable for conditions requiring anabolic support with a reduced side-effect burden.","oneSentence":"Org 50081 is a selective androgen receptor modulator (SARM) that binds to androgen receptors to promote anabolic effects while minimizing androgenic side effects.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:24:55.334Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Muscle wasting or sarcopenia (investigational)"}]},"trialDetails":[{"nctId":"NCT07430046","phase":"PHASE2","title":"Repurposing Mirtazapine in Rett Syndrome","status":"RECRUITING","sponsor":"University of Trieste","startDate":"2025-07-09","conditions":"RETT Syndrome With Proven MECP2 Mutation","enrollment":54},{"nctId":"NCT00488072","phase":"PHASE2","title":"Effects of Mirtazapine on Appetite in Advanced Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2007-01-08","conditions":"Advanced Cancer, Anorexia, Weight Loss","enrollment":98},{"nctId":"NCT06499090","phase":"EARLY_PHASE1","title":"Mirtazapine for Acute and Chronic Post Mastectomy Pain","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-03-01","conditions":"Breast Cancer","enrollment":62},{"nctId":"NCT04747314","phase":"PHASE2, PHASE3","title":"Treating Negative Affect in Low Back Pain Patients","status":"COMPLETED","sponsor":"Ajay Wasan, MD, Msc","startDate":"2021-03-31","conditions":"Chronic Low Back Pain, Negative Affectivity","enrollment":308},{"nctId":"NCT07328373","phase":"","title":"Neurobiological and Genomic Predictors of Relapse in Depression","status":"RECRUITING","sponsor":"Mehmet Kemal Arikan","startDate":"2025-01-01","conditions":"Healthy, Major Depressive Disorder (MDD)","enrollment":204},{"nctId":"NCT06684470","phase":"EARLY_PHASE1","title":"Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-12-19","conditions":"IBS - Irritable Bowel Syndrome, Diarrhea","enrollment":20},{"nctId":"NCT07211724","phase":"NA","title":"Methamphetamine Use Disorder Support in Heart Failure Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2025-11-01","conditions":"Heart Failure, Methamphetamine Use Disorder","enrollment":50},{"nctId":"NCT03935685","phase":"PHASE2","title":"Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Irvine","startDate":"2019-02-26","conditions":"Glioma of Brain","enrollment":120},{"nctId":"NCT06443242","phase":"NA","title":"Efficacy and Safety of Low-dose Laser Acupuncture on Treating Insomnia Associated With Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Mohammad Farris Iman Leong Bin Abdullah","startDate":"2025-12-01","conditions":"Major Depressive Disorder, Insomnia","enrollment":120},{"nctId":"NCT06591091","phase":"PHASE2","title":"Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-09","conditions":"Depression","enrollment":80},{"nctId":"NCT06530290","phase":"PHASE2","title":"Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients","status":"RECRUITING","sponsor":"Leila Dargahi. PharmD PhD","startDate":"2022-06-01","conditions":"Parkinson Disease, Anxiety","enrollment":64},{"nctId":"NCT03852160","phase":"PHASE3","title":"A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression","status":"WITHDRAWN","sponsor":"Janssen-Cilag International NV","startDate":"2019-12-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":""},{"nctId":"NCT06323837","phase":"PHASE2","title":"Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment","status":"RECRUITING","sponsor":"Washington State University","startDate":"2024-06-17","conditions":"Stimulant Use Disorder","enrollment":60},{"nctId":"NCT05452174","phase":"PHASE1, PHASE2","title":"Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP)","status":"WITHDRAWN","sponsor":"Northwestern University","startDate":"2022-06-13","conditions":"Pregnancy, Severe Nausea and Vomiting, Hyperemesis Gravidarum","enrollment":""},{"nctId":"NCT05431374","phase":"NA","title":"Measurement-Based Care Vs. Standard Care for Major Depressive Disorder","status":"COMPLETED","sponsor":"Pakistan Institute of Living and Learning","startDate":"2022-09-01","conditions":"Major Depressive Disorder","enrollment":150},{"nctId":"NCT04446039","phase":"","title":"Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea","status":"COMPLETED","sponsor":"Pfizer","startDate":"2022-07-04","conditions":"Major Depression","enrollment":370212},{"nctId":"NCT06681805","phase":"NA","title":"Prophylactic Mirtazapine and Different Doses of Intrathecal Morphine in Preventing Nausea and Vomiting After Cesarean Section","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2023-01-01","conditions":"Prophylactic, Mirtazapine, Intrathecal","enrollment":120},{"nctId":"NCT04547842","phase":"EARLY_PHASE1","title":"Mirtazapine Versus Dexamethasone in Preventing Postoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-09-01","conditions":"Post Operative Nausea and Vomiting","enrollment":90},{"nctId":"NCT04614584","phase":"PHASE1","title":"Mirtazapine and Methamphetamine Drug-drug Interaction Study","status":"COMPLETED","sponsor":"San Francisco Department of Public Health","startDate":"2021-05-03","conditions":"Methamphetamine Use Disorder, Drug Interaction, Cardiovascular Abnormalities","enrollment":15},{"nctId":"NCT05170919","phase":"PHASE2","title":"Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"Englewood Hospital and Medical Center","startDate":"2022-01-20","conditions":"Anorexia Nervosa with Significantly Low Body Weight","enrollment":170},{"nctId":"NCT06309472","phase":"PHASE2","title":"Trial of Mirtazapine for Depression in IBD","status":"RECRUITING","sponsor":"King's College London","startDate":"2024-05-01","conditions":"Major Depressive Disorder, Inflammatory Bowel Diseases","enrollment":76},{"nctId":"NCT00835575","phase":"PHASE1","title":"15 mg Mirtazapine Orally Disintegrating Tablets, Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-07","conditions":"Healthy","enrollment":32},{"nctId":"NCT00834197","phase":"PHASE1","title":"15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-07","conditions":"Healthy","enrollment":32},{"nctId":"NCT05247697","phase":"PHASE1","title":"Mirtazapine for Chronic Insomnia in Older Adults","status":"COMPLETED","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2022-10-01","conditions":"Chronic Insomnia","enrollment":60},{"nctId":"NCT01240096","phase":"PHASE4","title":"Mirtazapine Versus Placebo in Functional Dyspepsia","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2006-09-01","conditions":"Functional Dyspepsia","enrollment":35},{"nctId":"NCT06054321","phase":"NA","title":"Psychopharmacotherapy for Depressive Patients","status":"RECRUITING","sponsor":"Chonnam National University Hospital","startDate":"2022-08-03","conditions":"Major Depressive Disorder","enrollment":400},{"nctId":"NCT05978219","phase":"PHASE4","title":"Efficacy of Mirtazapine in Major Depressive Disorder With Insomnia","status":"COMPLETED","sponsor":"National Institute of Mental Health, Dhaka","startDate":"2023-05-25","conditions":"Major Depressive Disorder With Insomnia","enrollment":135},{"nctId":"NCT03377660","phase":"","title":"Resection of the Esophagus and Subsequent Weight Loss","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2018-01-01","conditions":"Esophageal Cancer, Weight Gain, Eating Behavior","enrollment":30},{"nctId":"NCT02893371","phase":"","title":"Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2016-09","conditions":"Bipolar Disorder","enrollment":1037352},{"nctId":"NCT05108688","phase":"PHASE4","title":"Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-11-15","conditions":"Headache","enrollment":210},{"nctId":"NCT06213948","phase":"PHASE1","title":"Elucidating Mechanisms That Underlie the Symptomatology of Functional Dyspepsia Using Novel Techniques and Its Therapeutic Validation Using Neuromodulators","status":"UNKNOWN","sponsor":"Universiti Sains Malaysia","startDate":"2021-08-01","conditions":"Functional Disorder of Stomach, Healthy","enrollment":54},{"nctId":"NCT04437485","phase":"PHASE2","title":"eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk","status":"COMPLETED","sponsor":"Indiana University","startDate":"2020-10-14","conditions":"Depression, Major Depressive Disorder, Dysthymic Disorder","enrollment":46},{"nctId":"NCT02458690","phase":"PHASE2","title":"eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients","status":"COMPLETED","sponsor":"Indiana University","startDate":"2015-07","conditions":"Depression, Major Depressive Disorder, Dysthymic Disorder","enrollment":216},{"nctId":"NCT05889234","phase":"","title":"Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2023-11-06","conditions":"Major Depressive Disorder, Magnetic Resonance Imaging, Electroconvulsive Therapy","enrollment":180},{"nctId":"NCT05931965","phase":"NA","title":"Combination Therapy of Different Antidepressants With Dietary Supplements","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2022-10-05","conditions":"Depression","enrollment":88},{"nctId":"NCT05952713","phase":"","title":"Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder","status":"COMPLETED","sponsor":"Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital","startDate":"2022-10-01","conditions":"Major Depressive Disorder","enrollment":73336},{"nctId":"NCT03283488","phase":"PHASE2","title":"Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2019-03-26","conditions":"Cachexia; Cancer, Anorexia","enrollment":52},{"nctId":"NCT02058693","phase":"PHASE4","title":"Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2010-12","conditions":"Major Depressive Disorder","enrollment":41},{"nctId":"NCT04763135","phase":"PHASE3","title":"Mirtazapine in Cancer-related Poly-symptomatology","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2021-12-15","conditions":"Cancer, Neoplasms, Neoplasm Metastasis","enrollment":1},{"nctId":"NCT04728581","phase":"NA","title":"Improving Sleep After TKA Using Mirtazapine and Quetiapine","status":"NOT_YET_RECRUITING","sponsor":"St. Anna Ziekenhuis, Geldrop, Netherlands","startDate":"2024-01-01","conditions":"Osteo Arthritis Knee, Insomnia","enrollment":165},{"nctId":"NCT05833399","phase":"","title":"Correlation of Genetic Variations With Clinical Response in Substance Use Disorder","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2022-11-28","conditions":"Substance Use Disorders, Substance Dependence","enrollment":200},{"nctId":"NCT04748523","phase":"NA","title":"Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia","status":"COMPLETED","sponsor":"Instituto Nacional de Cancerologia de Mexico","startDate":"2018-08-29","conditions":"Anorexia, Non-small Cell Lung Cancer","enrollment":86},{"nctId":"NCT05737511","phase":"PHASE4","title":"Efficacy of Hydroxyzine for Patients With Panic Disorder","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2023-12-30","conditions":"Panic Disorder","enrollment":80},{"nctId":"NCT03785691","phase":"PHASE2","title":"Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum","status":"TERMINATED","sponsor":"Nordsjaellands Hospital","startDate":"2019-03-01","conditions":"Hyperemesis Gravidarum, Nausea Gravidarum, Vomiting of Pregnancy","enrollment":58},{"nctId":"NCT04155008","phase":"PHASE4","title":"Nutrition and Pharmacological Algorithm for Oncology Patients Study","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2021-03-01","conditions":"Oncologic Complications, Quality of Life, Nutrition Poor","enrollment":1},{"nctId":"NCT01962753","phase":"NA","title":"Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2012-05-10","conditions":"Elderly, Major Depression","enrollment":92},{"nctId":"NCT05380479","phase":"PHASE2","title":"Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.","status":"UNKNOWN","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2022-06-01","conditions":"Anorexia","enrollment":80},{"nctId":"NCT02336750","phase":"PHASE3","title":"Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis","status":"COMPLETED","sponsor":"Fudan University","startDate":"2014-12","conditions":"Breast Cancer","enrollment":212},{"nctId":"NCT04908605","phase":"PHASE4","title":"Emergence Agitation After Nasal Surgery: a Randomized Controlled Comparison Between Melatonin and Mirtazapine","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-06-15","conditions":"Agitation","enrollment":165},{"nctId":"NCT03921151","phase":"PHASE1, PHASE2","title":"5HT2CR Balance in Brain Connectivity in Cocaine Dependence","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2014-05-13","conditions":"Cocaine Dependence","enrollment":90},{"nctId":"NCT03294525","phase":"","title":"Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders","status":"UNKNOWN","sponsor":"Peking University","startDate":"2016-01","conditions":"Affective Disorder","enrollment":400},{"nctId":"NCT02655354","phase":"NA","title":"A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity","status":"COMPLETED","sponsor":"University of Washington","startDate":"2015-10","conditions":"Posttraumatic Stress Disorder, Depression, Alcohol-Related Disorders","enrollment":635},{"nctId":"NCT04799782","phase":"PHASE2","title":"Role of Mirtazapine in Ameliorating Sleep Disordered Breathing","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2017-01","conditions":"Spinal Cord Injuries, Sleep Disordered Breathing","enrollment":18},{"nctId":"NCT00564278","phase":"NA","title":"Effects of Adding Motivational Interviewing to Antidepressant Treatment for Hispanic Adults With Depression","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2008-02","conditions":"Depression","enrollment":217},{"nctId":"NCT03031184","phase":"PHASE3","title":"Study of Mirtazapine for Agitation in Dementia","status":"COMPLETED","sponsor":"University of Sussex","startDate":"2017-01","conditions":"Dementia","enrollment":207},{"nctId":"NCT04806230","phase":"","title":"Serum Concentrations of Antidepressant Drugs in Pregnant Women - a Naturalistic Study","status":"COMPLETED","sponsor":"Linkoeping University","startDate":"2011-04-01","conditions":"Pharmacokinetics, Antidepressive Agents, Pregnancy","enrollment":81},{"nctId":"NCT00750919","phase":"PHASE3","title":"Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-10-07","conditions":"Sleep Initiation and Maintenance Disorders, Mental Disorders, Dyssomnias","enrollment":184},{"nctId":"NCT00561574","phase":"PHASE3","title":"A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-01-09","conditions":"Sleep Initiation and Maintenance Disorder; Elderly, Mental Disorder, Dyssomnias","enrollment":259},{"nctId":"NCT03675555","phase":"PHASE4","title":"Prophylactic Mirtazapine or Dexamethasone for Post-spinal Anesthesia Shivering","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2018-03-01","conditions":"Shivering","enrollment":300},{"nctId":"NCT00150839","phase":"PHASE4","title":"Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy","status":"COMPLETED","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2006-03","conditions":"Depressive Disorder, Major","enrollment":80},{"nctId":"NCT00080158","phase":"PHASE2, PHASE3","title":"Treatment of Adolescent Suicide Attempters (TASA)","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2004-03","conditions":"Depression, Suicide, Attempted","enrollment":120},{"nctId":"NCT01465919","phase":"PHASE4","title":"Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C","status":"TERMINATED","sponsor":"Seoul National University Boramae Hospital","startDate":"2011-08","conditions":"Depression","enrollment":5},{"nctId":"NCT00742573","phase":"PHASE2","title":"Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2008-08","conditions":"Major Depressive Disorder","enrollment":170},{"nctId":"NCT03254173","phase":"PHASE2, PHASE3","title":"Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia","status":"COMPLETED","sponsor":"Catherine Naseef Hunter","startDate":"2018-03-26","conditions":"Advanced Cancer, Cancer Associated Anorexia - Cachexia","enrollment":120},{"nctId":"NCT04013386","phase":"PHASE4","title":"Effects of Aprepitant/Dexamethasone Versus Mertazepine /Dexamethasone on Postoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2019-07-15","conditions":"Nausea and Vomiting, Postoperative","enrollment":90},{"nctId":"NCT03148522","phase":"NA","title":"A Diagnosis and Treatment Optimization Study of Depression Based on the Neurological Mechanism of Reward System","status":"UNKNOWN","sponsor":"Peking University","startDate":"2017-06-01","conditions":"Diagnosis and Treatment of Depression","enrollment":120},{"nctId":"NCT02711215","phase":"PHASE4","title":"Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR)","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2015-05","conditions":"Major Depressive Disorder","enrollment":80},{"nctId":"NCT00535288","phase":"PHASE3","title":"Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-09-15","conditions":"Postmenopausal Symptoms, Menopause, Vasomotor Symptoms","enrollment":946},{"nctId":"NCT00560833","phase":"PHASE3","title":"Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-10-15","conditions":"Menopause, Vasomotor Symptoms","enrollment":943},{"nctId":"NCT00732901","phase":"PHASE2, PHASE3","title":"Clinical Neurobiology of Serotonin and Addiction","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2008-06","conditions":"Cocaine Dependence","enrollment":160},{"nctId":"NCT01302964","phase":"PHASE3","title":"Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2010-08","conditions":"Autism Spectrum Disorders","enrollment":30},{"nctId":"NCT00482612","phase":"PHASE3","title":"Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-12-07","conditions":"Insomnia","enrollment":526},{"nctId":"NCT00561821","phase":"PHASE3","title":"Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-11-20","conditions":"Insomnia, Sleep Initiation and Maintenance Disorders, Mental Disorders","enrollment":538},{"nctId":"NCT00610675","phase":"PHASE3","title":"Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-12-07","conditions":"Insomnia","enrollment":346},{"nctId":"NCT00631657","phase":"PHASE3","title":"A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-03-04","conditions":"Sleep Initiation and Maintenance Disorders, Mental Disorders, Dyssomnias","enrollment":460},{"nctId":"NCT00506389","phase":"PHASE3","title":"A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-06-06","conditions":"Insomnia","enrollment":419},{"nctId":"NCT03679052","phase":"PHASE4","title":"Prophylactic Mirtazapine or Clonidine for Post-spinal Anesthesia Shivering","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2018-03-01","conditions":"Shivering","enrollment":300},{"nctId":"NCT01421342","phase":"PHASE3","title":"VA Augmentation and Switching Treatments for Improving Depression Outcomes","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2012-12","conditions":"Major Depressive Disorder","enrollment":1522},{"nctId":"NCT02441387","phase":"","title":"Predictors of the Outcome of Late Life Depression","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2015-04","conditions":"Major Depression","enrollment":120},{"nctId":"NCT00832520","phase":"PHASE2","title":"Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight","status":"TERMINATED","sponsor":"New Mexico Cancer Research Alliance","startDate":"2008-11","conditions":"Advanced Cancer","enrollment":13},{"nctId":"NCT01165541","phase":"PHASE2","title":"A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2010-09","conditions":"Alcohol Dependence","enrollment":20},{"nctId":"NCT01943435","phase":"NA","title":"Study Comparing 3 Different Treatments for Arthritis of the Lower Back (Lumbar Spinal Stenosis)","status":"COMPLETED","sponsor":"Michael Schneider, DC, PhD","startDate":"2013-11-20","conditions":"Lumbar Spinal Stenosis","enrollment":259},{"nctId":"NCT01888835","phase":"PHASE2","title":"Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)","status":"COMPLETED","sponsor":"Phillip Coffin, MD, MIA","startDate":"2013-08","conditions":"Amphetamine-Related Disorders","enrollment":120},{"nctId":"NCT02374567","phase":"PHASE3","title":"Pharmacovigilance in Gerontopsychiatric Patients","status":"TERMINATED","sponsor":"Hannover Medical School","startDate":"2015-01","conditions":"Dementia, Depression, Schizophrenia","enrollment":407},{"nctId":"NCT00057551","phase":"PHASE4","title":"Research Evaluating the Value of Augmenting Medication With Psychotherapy","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2003-04","conditions":"Depression, Depressive Disorder","enrollment":491},{"nctId":"NCT01916824","phase":"PHASE4","title":"Effects of Treatment on Decision-making in Major Depression","status":"COMPLETED","sponsor":"Emory University","startDate":"2013-08","conditions":"Major Depressive Disorder, Healthy Controls","enrollment":53},{"nctId":"NCT00249444","phase":"PHASE2","title":"Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2006-05","conditions":"Cocaine Dependence, Depression","enrollment":86},{"nctId":"NCT03219008","phase":"PHASE4","title":"Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics","status":"UNKNOWN","sponsor":"Shanghai Mental Health Center","startDate":"2017-08-01","conditions":"Depressive Disorder","enrollment":800},{"nctId":"NCT01458626","phase":"PHASE4","title":"Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2012-11-14","conditions":"Major Depression","enrollment":525},{"nctId":"NCT02400346","phase":"PHASE3","title":"Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2015-03","conditions":"Major Depression Disorder","enrollment":132},{"nctId":"NCT02185131","phase":"PHASE2","title":"Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2013-09","conditions":"Major Depressive Disorder, Alcohol Use Disorder","enrollment":16},{"nctId":"NCT02646449","phase":"PHASE2","title":"Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2015-06","conditions":"Major Depressive Disorder, Alcohol Use Disorder","enrollment":11},{"nctId":"NCT01944657","phase":"NA","title":"Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study","status":"WITHDRAWN","sponsor":"Sheppard Pratt Health System","startDate":"2013-09","conditions":"1. Major Depressive Disorder","enrollment":""},{"nctId":"NCT00322309","phase":"PHASE2","title":"Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects","status":"COMPLETED","sponsor":"Boston University","startDate":"2005-09","conditions":"Cocaine Dependence, Depression","enrollment":24},{"nctId":"NCT01725048","phase":"EARLY_PHASE1","title":"Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2011-01","conditions":"Major Depressive Disorder, Neoplasms","enrollment":21},{"nctId":"NCT01109693","phase":"PHASE4","title":"Strategic Use of New Generation Antidepressants for Depression","status":"COMPLETED","sponsor":"Kyoto University","startDate":"2010-12","conditions":"Unipolar Major Depressive Episode","enrollment":2011},{"nctId":"NCT01263080","phase":"PHASE4","title":"Evaluation of Mirtazapine and Folic Acid for Schizophrenia:","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2010-11","conditions":"Schizophrenia","enrollment":333},{"nctId":"NCT01601002","phase":"PHASE4","title":"LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2012-06","conditions":"Major Depressive Disorder","enrollment":19},{"nctId":"NCT01178671","phase":"PHASE4","title":"Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial","status":"COMPLETED","sponsor":"Research Foundation for Mental Hygiene, Inc.","startDate":"2010-07","conditions":"Posttraumatic Stress Disorder","enrollment":38},{"nctId":"NCT02650544","phase":"PHASE2","title":"Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2015-12","conditions":"Carcinoma, Non-Small-Cell Lung, Depression","enrollment":236}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Org 50081","genericName":"Org 50081","companyName":"Merck Sharp & Dohme LLC","companyId":"merck-sharp-dohme-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Org 50081 is a selective androgen receptor modulator (SARM) that binds to androgen receptors to promote anabolic effects while minimizing androgenic side effects. Used for Muscle wasting or sarcopenia (investigational).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}